This report shows how biopharmaceutical research companies continue to be vitally important to the economy and patient health in New Jersey.

Since 2004, biopharmaceutical research companies are conducting or have conducted more than 4,900 clinical trials of new medicines in New Jersey in collaboration with clinical research centers and hospitals. These clinical trials have investigated or are investigating some of New Jersey’s biggest health care challenges, including asthma, arthritis, cancer, diabetes, cardiovascular disease and Alzheimer’s disease.